Sensei Biotherapeutics, Inc. (SNSE) Tops Q3 EPS by 2c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.29), $0.02 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood Markets (HOOD) PT Raised to $130 at Cantor Fitzgerald
• SpaceX signs compute deal with Reflection - CNBC